Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers

NCT00898573 is registered in ClinicalTrials.gov with Case Comprehensive Cancer Center as lead sponsor.

NCT NCT00898573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00898573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers
Lead sponsor
Case Comprehensive Cancer Center
Phase
Observational
Overall status
Withdrawn
Start date
July 31, 2008
Completion date
Not reported
Enrollment
0 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer